Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
Diabetes Care - United States
doi 10.2337/dc15-0781
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2015
Authors
Publisher
American Diabetes Association